ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits
Journal of Diabetes Research · 2025
DOI: 10.1155/jdr/5519447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2025. Verfasst von Hana Drobiova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Kuwait University, Jabriya, Kuwait. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Membrane Proteins, ADAM Proteins, Metabolic Syndrome. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kuwait University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
A disintegrin and metalloproteinase Domain 9 (ADAM9) is a zinc‐dependent proteinase involved in various biological processes. However, its role in the pathophysiology of metabolic syndrome remains unclear, and studies exploring the association between ADAM9 polymorphisms and metabolic traits are limited. In this study, we investigated the potential link between ADAM9 variants and metabolic syndrome traits in a cohort of adult participants from Kuwait. Using a genome‐wide association study (GWAS), followed by a replication study, we identified two ADAM9 variants—ADAM9‐E76K (rs61753672) and ADAM9‐P750L (rs144750648)—that were associated with various metabolic traits. The replication phase confirmed the association of ADAM9‐P750L with HbA1c levels and revealed new associations with systolic blood pressure, waist‐to‐hip ratio, fasting blood glucose, triglycerides, and cholesterol. Functional analysis showed that both variants exhibited reduced proteolytic activity, potentially contributing to the pathogenesis of Type 2 diabetes. These findings suggest that ADAM9 variants may play a significant role in metabolic health and diabetes risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine, Kuwait University, Jabriya, Kuwait.
- Translational Medicine Department, Dasman Diabetes Institute, Dasman, Kuwait.
ORCID-Profile: Hana Drobiova, Fahd Al-Mulla, Rabeah Al-Temaimi
Förderung
- Kuwait University
Zitieren
APA
Drobiova, H., Al-Mulla, F., & Al-Temaimi, R. (2025). ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits. Journal of Diabetes Research. https://doi.org/10.1155/jdr/5519447
Vancouver
Drobiova H, Al-Mulla F, Al-Temaimi R. ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits. Journal of Diabetes Research. 2025. doi:10.1155/jdr/5519447
BibTeX
@article{Drobiova2025,
author = {Drobiova, Hana and Al-Mulla, Fahd and Al-Temaimi, Rabeah},
title = {ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits},
journal = {Journal of Diabetes Research},
year = {2025},
doi = {10.1155/jdr/5519447}
}
EUVIMED